Page last updated: 2024-08-21

bufogenin and Pancreatic Neoplasms

bufogenin has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, H; Liu, L; Liu, X; Liu, Y; Mao, G; Song, D; Yin, M; Zeng, Q; Zhang, N	1

Other Studies

1 other study(ies) available for bufogenin and Pancreatic Neoplasms

Article	Year
Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3. Cancer science, 2018, Volume: 109, Issue:11 Topics: Animals; Bufanolides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; MAP Kinase Kinase Kinases; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Xenograft Model Antitumor Assays	2018

Article

Year

Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.

Cancer science, 2018, Volume: 109, Issue:11

Topics: Animals; Bufanolides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; MAP Kinase Kinase Kinases; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Xenograft Model Antitumor Assays

2018